SG11201909368TA - Compositions and systems for renal function determination - Google Patents

Compositions and systems for renal function determination

Info

Publication number
SG11201909368TA
SG11201909368TA SG11201909368TA SG11201909368TA SG 11201909368T A SG11201909368T A SG 11201909368TA SG 11201909368T A SG11201909368T A SG 11201909368TA SG 11201909368T A SG11201909368T A SG 11201909368TA
Authority
SG
Singapore
Prior art keywords
louis
international
missouri
suite
square drive
Prior art date
Application number
Other languages
English (en)
Inventor
Martin P Debreczeny
Raghavan Rajagopalan
Richard B Dorshow
William L Neumann
Thomas E Rogers
Original Assignee
Medibeacon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medibeacon Inc filed Critical Medibeacon Inc
Publication of SG11201909368TA publication Critical patent/SG11201909368TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1495—Calibrating or testing of in-vivo probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • A61B5/201—Assessing renal or kidney functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6814—Head
    • A61B5/6815—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0093—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Physiology (AREA)
  • Signal Processing (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Otolaryngology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201909368T 2017-10-27 2018-10-26 Compositions and systems for renal function determination SG11201909368TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762577962P 2017-10-27 2017-10-27
PCT/US2018/057820 WO2019084475A1 (en) 2017-10-27 2018-10-26 COMPOSITIONS AND SYSTEMS FOR MEASURING RENAL FUNCTION

Publications (1)

Publication Number Publication Date
SG11201909368TA true SG11201909368TA (en) 2019-11-28

Family

ID=66245914

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201909368T SG11201909368TA (en) 2017-10-27 2018-10-26 Compositions and systems for renal function determination

Country Status (16)

Country Link
US (2) US11602570B2 (es)
EP (1) EP3700578A4 (es)
JP (3) JP7202355B2 (es)
KR (3) KR20200010191A (es)
CN (1) CN110494167A (es)
AU (1) AU2018355541B2 (es)
BR (1) BR112019020605A2 (es)
CA (1) CA3058772C (es)
IL (1) IL269617B1 (es)
MX (2) MX2019011977A (es)
MY (1) MY197859A (es)
NZ (1) NZ757917A (es)
PH (1) PH12019502352A1 (es)
RU (2) RU2760279C2 (es)
SG (1) SG11201909368TA (es)
WO (1) WO2019084475A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3665705A1 (en) 2017-08-08 2020-06-17 Fresenius Medical Care Holdings, Inc. Systems and methods for treating and estimating progression of chronic kidney disease
MX2021006957A (es) * 2018-12-12 2021-07-15 Medibeacon Inc Usos de la medicion de la velocidad de filtracion glomerular transdermica en terapia continua de reemplazo renal.
US20220315538A1 (en) * 2021-03-31 2022-10-06 Medibeacon Inc. Purification of substituted diaminopyrazine dicarboxylic acids
TW202321203A (zh) * 2021-08-11 2023-06-01 中國大陸商杭州中美華東製藥有限公司 製備作為螢光示蹤劑的吡嗪羧酸類衍生物的方法
WO2023025271A1 (zh) * 2021-08-27 2023-03-02 杭州中美华东制药有限公司 吡嗪类衍生物的晶型及其制备方法
CN118103355A (zh) * 2021-09-24 2024-05-28 杭州中美华东制药有限公司 用于制备作为荧光示踪剂的吡嗪羧酸类衍生物的氢化合成方法
WO2023078440A1 (zh) * 2021-11-08 2023-05-11 杭州中美华东制药有限公司 吡嗪类衍生物的盐的晶型及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5301673A (en) * 1991-11-18 1994-04-12 Massachusetts General Hospital Ambulatory clearance function monitor
US6280703B1 (en) * 1997-03-13 2001-08-28 Mallinckrodt Inc. Simultaneous multimodal measurement of physiological function
US6909912B2 (en) 2002-06-20 2005-06-21 University Of Florida Non-invasive perfusion monitor and system, specially configured oximeter probes, methods of using same, and covers for probes
WO2004096082A2 (en) 2003-04-24 2004-11-11 The Board Of Regents Of The University Of Texas System Noninvasive blood analysis by optical probing of the veins under the tongue
US20060095102A1 (en) 2003-09-17 2006-05-04 Thomas Perez Method and apparatus for sublingual application of light to blood
ATE466000T1 (de) * 2004-12-23 2010-05-15 Mallinckrodt Inc Fluoreszente pyrazinderivate und verfahren zu deren anwendung bei der bewertung der nierenfunktion
US8664392B2 (en) 2004-12-23 2014-03-04 Medibeacon, LLC Pyrazine derivatives for bioconjugation
US7710872B2 (en) 2005-12-14 2010-05-04 Cisco Technology, Inc. Technique for enabling traffic engineering on CE-CE paths across a provider network
EP1986701B1 (en) 2006-02-24 2012-06-13 Mallinckrodt LLC Optical agents for use in surgery
JP2009534396A (ja) * 2006-06-22 2009-09-24 マリンクロッド・インコーポレイテッド ピラジン誘導体および腎臓の監視におけるその使用
JP2009541323A (ja) 2006-06-22 2009-11-26 マリンクロット インコーポレイテッド 拡張された共役を有するピラジン誘導体およびその使用
CA2721846C (en) 2008-04-18 2021-01-26 Pharmacophotonics, Inc. Renal function analysis method and apparatus
US8591865B2 (en) 2008-04-18 2013-11-26 Pharmacophotonics, Inc. Renal function analysis method and apparatus
EP2376458A1 (en) * 2008-12-17 2011-10-19 Mallinckrodt LLC Modified pyrazine derivatives and uses thereof
US9554739B2 (en) * 2009-09-29 2017-01-31 Covidien Lp Smart cable for coupling a medical sensor to an electronic patient monitor
US20120172679A1 (en) 2010-12-30 2012-07-05 Logan Robert J Systems and methods for monitoring and processing biometric data
AU2012249600B2 (en) 2011-04-26 2016-05-19 Incube Labs, Llc Mouthpiece for measurement of biometric data of a diver and underwater communication
WO2013170219A1 (en) * 2012-05-11 2013-11-14 BioMetric Holdings, Inc. Systems, methods, and apparatuses for monitoring end stage renal disease
ES2723892T3 (es) 2013-10-22 2019-09-03 Medibeacon Inc Medición mejorada de función de órgano transcutáneo
US11077211B2 (en) * 2013-11-11 2021-08-03 Medibeacon Inc. Compositions and methods for assessing gut function
JP2016112375A (ja) * 2014-12-16 2016-06-23 イオム株式会社 皮膚蛍光測定装置
US10525149B2 (en) * 2015-05-12 2020-01-07 Medibeacon Inc. Compositions and methods for assessing eye vasculature
MX2019009040A (es) 2017-01-30 2019-11-11 Medibeacon Inc Metodo para monitoreo no invasivo de agente trazador fluorescente con correcciones de reflejo difuso.
CA3058767C (en) * 2017-10-27 2022-03-15 Medibeacon Inc. Methods for renal function determination

Also Published As

Publication number Publication date
EP3700578A1 (en) 2020-09-02
JP7202355B2 (ja) 2023-01-11
IL269617A (en) 2019-11-28
BR112019020605A2 (pt) 2020-04-22
WO2019084475A1 (en) 2019-05-02
MX2023011017A (es) 2023-09-27
CN110494167A (zh) 2019-11-22
NZ757917A (en) 2022-04-29
RU2760279C2 (ru) 2021-11-23
MX2019011977A (es) 2020-01-27
AU2018355541B2 (en) 2020-11-19
IL269617B1 (en) 2024-05-01
CA3058772C (en) 2023-08-08
RU2021133174A (ru) 2021-12-02
KR20200010191A (ko) 2020-01-30
MY197859A (en) 2023-07-20
AU2018355541A1 (en) 2019-10-31
PH12019502352A1 (en) 2020-12-07
US20230173111A1 (en) 2023-06-08
KR20230054506A (ko) 2023-04-24
JP2023175915A (ja) 2023-12-12
EP3700578A4 (en) 2021-08-04
JP2020516680A (ja) 2020-06-11
US11602570B2 (en) 2023-03-14
CA3058772A1 (en) 2019-05-02
RU2019132431A (ru) 2021-04-14
JP2023009041A (ja) 2023-01-19
JP7362869B2 (ja) 2023-10-17
US20190125901A1 (en) 2019-05-02
RU2019132431A3 (es) 2021-04-14
KR20220003659A (ko) 2022-01-10

Similar Documents

Publication Publication Date Title
SG11201909368TA (en) Compositions and systems for renal function determination
SG11201909367VA (en) Methods for renal function determination
SG11201805217XA (en) Compositions and methods for the treatment of hemoglobinopathies
SG11201807002TA (en) Intention signaling for an autonomous vehicle
SG11201804696RA (en) Techniques for metadata processing
SG11201803983UA (en) Transformable tagging compositions, methods, and processes incorporating same
SG11201901364VA (en) Engineered target specific nucleases
SG11201901531TA (en) Regulation of gene expression using engineered nucleases
SG11201809437TA (en) Intracellular delivery of biomolecules to induce tolerance
SG11202000145XA (en) Methods and systems for conditionally regulating gene expression
SG11201900274VA (en) Event trigger for independent links
SG11201804528YA (en) Multi-passenger ride vehicle
SG11201811426UA (en) Distributed electronic record and transaction history
SG11201805422WA (en) Multivalent and multispecific ox40-binding fusion proteins
SG11201906372PA (en) Computer-implemented system and method for generating and extracting user related data stored on a blockchain
SG11201811034PA (en) Air treatment systems and methods
SG11201903958SA (en) Intuitive occluded object indicator
SG11201901020RA (en) Anti-siglec-7 antibodies for the treatment of cancer
SG11201908847TA (en) Apparatuses, systems and methods for imaging flow cytometry
SG11201900501RA (en) Cannabis composition
SG11201909011PA (en) Niraparib compositions
SG11201907776WA (en) Replication lag-constrained deletion of data in a large-scale distributed data storage system
SG11201805874VA (en) Method and apparatus for adding notification objects
SG11201909561RA (en) Octree-based convolutional neural network
SG11201807134RA (en) Transposon system and methods of use